OPERATION OF AN IMPLANTABLE MEDICAL DEVICE SYSTEM TO DETERMINE HEART FAILURE RISK BASED ON POSTURE STATES

    公开(公告)号:US20250032052A1

    公开(公告)日:2025-01-30

    申请号:US18783886

    申请日:2024-07-25

    Abstract: A system includes an implantable medical device that includes an accelerometer sensing circuitry. Responsive to one or more of a first signal from the accelerometer satisfying a first threshold or a first heart rate determined from a first set of cardiac activity data satisfying a first heart rate threshold, processing circuitry of the system determines a first posture state based on the first signal. Responsive to one or more of a second signal satisfying a second threshold or a second heart rate determined from a second set of cardiac activity data satisfying a second heart rate threshold, the processing circuitry determines a second posture state based on the second signal. The processing circuitry determines a heart failure risk based on the first posture state and the second posture state and generates output based at least in part on the heart failure risk.

    CARDIAC SIGNAL QT INTERVAL DETECTION
    6.
    发明公开

    公开(公告)号:US20240206798A1

    公开(公告)日:2024-06-27

    申请号:US18538473

    申请日:2023-12-13

    CPC classification number: A61B5/352 A61B5/355 A61B5/36 A61B5/7203 A61B2560/02

    Abstract: An example device for detecting one or more parameters of a cardiac signal is disclosed herein. The device includes one or more electrodes and sensing circuitry configured to sense a cardiac signal via the one or more electrodes. The device further includes processing circuitry configured to determine an R-wave of the cardiac signal and determine whether the R-wave is noisy. Based on the R-wave being noisy, the processing circuitry is configured to determine whether the cardiac signal around a determined T-wave is noisy. Based on the cardiac signal around the determined T-wave not being noisy, the processing circuitry is configured to determine a QT interval or a corrected QT interval based on the determined T-wave and the determined R-wave.

    Cardiac signal QT interval detection

    公开(公告)号:US11918367B2

    公开(公告)日:2024-03-05

    申请号:US18164759

    申请日:2023-02-06

    CPC classification number: A61B5/352 A61B5/355 A61B5/36 A61B5/7203 A61B2560/02

    Abstract: An example device for detecting one or more parameters of a cardiac signal is disclosed herein. The device includes one or more electrodes and sensing circuitry configured to sense a cardiac signal via the one or more electrodes. The device further includes processing circuitry configured to determine an R-wave of the cardiac signal and determine whether the R-wave is noisy. Based on the R-wave being noisy, the processing circuitry is configured to determine whether the cardiac signal around a determined T-wave is noisy. Based on the cardiac signal around the determined T-wave not being noisy, the processing circuitry is configured to determine a QT interval or a corrected QT interval based on the determined T-wave and the determined R-wave.

    Heart failure monitoring
    10.
    发明授权

    公开(公告)号:US11723537B2

    公开(公告)日:2023-08-15

    申请号:US16719665

    申请日:2019-12-18

    Abstract: Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.

Patent Agency Ranking